Bulletin
Investor Alert

New York Markets Close in:

Gamida Cell Ltd.

NAS: GMDA

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 29, 2022, 1:09 p.m.

/zigman2/quotes/207657083/composite

$

1.74

Change

+0.12 +7.36%

Volume

Volume 957,849

Real time quotes

/zigman2/quotes/207657083/composite

Previous close

$ 1.62

$ 1.74

Change

+0.12 +7.36%

Day low

Day high

$1.60

$1.79

Open

52 week low

52 week high

$1.47

$4.72

Open

Julian Adams

Julian Adams is a businessperson who has been at the helm of 5 different companies. Currently, he occupies the position of Chairman of Elicio Therapeutics, Inc. and Chief Executive Officer & Director at Gamida Cell Ltd., Chief Executive Officer & Director at Gamida Cell, Inc. (a subsidiary of Gamida Cell Ltd.). Dr. Adams is also on the board of Princess Margaret Cancer Foundation.

Julian Adams previously occupied the position of President & Chief Science Officer at Clal Biotechnology Industries Ltd. and President & Chief Science Officer at Clal Biotechnology Industries Ltd. (Venture Capital) (a subsidiary of Clal Biotechnology Industries Ltd.), President-Research & Development at Infinity Pharmaceuticals, Inc. and President for Infinity Discovery, Inc. (a subsidiary of Infinity Pharmaceuticals, Inc.), Medicinal Chemist at Merck & Co., Inc., Advisor at Limulus Management Co. LLC, Senior Vice President-Research & Development at LeukoSite, Inc., Director, Executive VP-Research & Development at ProScript, Inc., Senior Vice President-Drug Discovery & Development at Millennium Pharmaceuticals, Inc. and Director-Medicinal Chemistry at Boehringer Ingelheim Corp.

Dr. Adams received an undergraduate degree from McGill University and a doctorate from Massachusetts Institute of Technology.

Transactions

Date Shares Transaction Value
07/27/2022 68,800   Award at $0 per share. 0
07/27/2022 48,500   Award at $0 per share. 0

Officers and Executives

Mr. Robert I. Blum
Chairman
Dr. Julian Adams
Chief Executive Officer & Director
Mr. Michele I. Korfin
Chief Operating & Commercial Officer
Mr. Shai Lankry
Chief Financial Officer
Dr. Yona Geffen
Vice President-Research & Development
Dr. Ronit Simantov
Chief Medical & Scientific Officer
Mr. Vladimir Melnikov
Senior VP-Global Operations & Manufacturing
Mr. Joshua F. Patterson
Chief Compliance Officer & General Counsel
Mr. Tzvi Palash
Chief Manufacturing Officer
Dr. Anat Cohen-Dayag
Director
Dr. Naama Halevi-Davidov
Director
Dr. Ivan M. Borrello
Director
Mr. Yisrael Gewirtz
Internal Auditor
Ms. Heather DiVecchia
Chief of Staff
Dr. Jas Uppal
Chief Regulatory & Quality Officer
Ms. Shawn Cline Tomasello
Independent Director
Mr. Stephen T. Wills
Independent Director
Mr. Kenneth I. Moch
Independent Non-Executive Director
Link to MarketWatch's Slice.